14
IRUS TotalDownloads
Altmetric
ERS/EAACI statement on severe exacerbations in asthma in adults: facts, priorities and key research questions
File | Description | Size | Format | |
---|---|---|---|---|
ERJ-00900-2019.R2_Proof_hi.pdf | Accepted version | 1.09 MB | Adobe PDF | View/Open |
Title: | ERS/EAACI statement on severe exacerbations in asthma in adults: facts, priorities and key research questions |
Authors: | Bourdin, A Bjermer, L Brightling, C Brusselle, GG Chanez, P Chung, KF Custovic, A Diamant, Z Diver, S Djukanovic, R Hamerlijnck, D Horvath, I Johnston, SL Kanniess, F Papadopoulos, N Papi, A Russell, RJ Ryan, D Samitas, K Tonia, T Zervas, E Gaga, M |
Item Type: | Journal Article |
Abstract: | Despite the use of effective medications to control asthma, severe exacerbations in asthma are still a major health risk and require urgent action on the part of the patient and physician to prevent serious outcomes such as hospitalisation or death. Moreover, severe exacerbations are associated with substantial healthcare costs and psychological burden, including anxiety and fear for patients and their families. The European Academy of Allergy and Clinical Immunology (EAACI) and the European Respiratory Society (ERS) set up a task force to search for a clear definition of severe exacerbations, and to also define research questions and priorities. The statement includes comments from patients who were members of the task force. |
Issue Date: | 1-Sep-2019 |
Date of Acceptance: | 17-Jul-2019 |
URI: | http://hdl.handle.net/10044/1/81234 |
DOI: | 10.1183/13993003.00900-2019 |
ISSN: | 0903-1936 |
Publisher: | European Respiratory Society |
Start Page: | 1 |
End Page: | 25 |
Journal / Book Title: | European Respiratory Journal |
Volume: | 54 |
Issue: | 3 |
Copyright Statement: | ©ERS 2019 |
Keywords: | Science & Technology Life Sciences & Biomedicine Respiratory System NEAR-FATAL ASTHMA SEVERE EOSINOPHILIC ASTHMA EXHALED NITRIC-OXIDE MODIFIABLE RISK-FACTORS DOSE INHALED CORTICOSTEROIDS INTERMITTENT BETA-AGONISTS GENOME-WIDE ASSOCIATION QUALITY-OF-LIFE DOUBLE-BLIND BUDESONIDE-FORMOTEROL Science & Technology Life Sciences & Biomedicine Respiratory System NEAR-FATAL ASTHMA SEVERE EOSINOPHILIC ASTHMA EXHALED NITRIC-OXIDE MODIFIABLE RISK-FACTORS DOSE INHALED CORTICOSTEROIDS INTERMITTENT BETA-AGONISTS GENOME-WIDE ASSOCIATION QUALITY-OF-LIFE DOUBLE-BLIND BUDESONIDE-FORMOTEROL 11 Medical and Health Sciences Respiratory System |
Publication Status: | Published |
Article Number: | ARTN 1900900 |
Online Publication Date: | 2019-09-28 |
Appears in Collections: | National Heart and Lung Institute Airway Disease |